Pam Randhawa is CEO and Founder of Empiriko, an early-stage biotech company focused on developing antiviral therapeutics and home/clinic-based point-of-care diagnostics for personalized patient treatment and monitoring. Pam has over 20 years of leadership experience in the healthcare/life sciences industries with expertise ranging from policy, corporate strategy, product development, advanced analytics and marketing for Fortune 500 companies, startups, and government. Prior to founding Empiriko, she co-founded AgroGreen Biofuels, an alternative biofuels technology company using agriculture waste.
Previously, Pam held several executive positions with major healthcare technology companies. She also served as an independent consultant to the State of Ohio, Department of Health, where she led a statewide taskforce for Health Status of Ohioans for the State Health Plan.
Pam serves on the Board of Directors of the Massachusetts Life Sciences Center (MLSC), a state investment agency responsible for $1.6 billion fund to support life sciences innovation. Pam also serves on the Board of Directors of Hercules Capital with $15 billion under management. She serves on the advisory board of ENTRx, a biotech company developing therapeutics targeted for ear diseases.
Pam is a member of the Silent Spring Institute’s Leadership Council which studies the links between the environment and women’s health, with a focus on breast cancer. Previously, she served on several boards and councils, including the World Economic Forum’s Global Future Council on Biotechnology; the NSF/NIJ Industrial Advisory Board of Center for Advanced Research in Forensic Science chair; the NIH review panel for SBIR/STTR Commercialization Readiness Pilot Program, the Economic Development Planning Council for the State of MA and the Women’s Workforce Council to eliminate the gender wage gap. She serves as a judge for the Harvard Business School’s New Venture Competition.
Pam holds a bachelor’s degree in economics from the University of Rajasthan, India, and earned a master’s degree from the Heinz School of Public Policy and Management at Carnegie-Mellon University.